Alliqua, Inc. (NASDAQ:ALQA) a provider of advanced wound care products, has acquired Choice Therapeutics, Inc. (“Choice Therapeutics”), a privately held wound care company with proprietary technologies and products, for approximately $4 million in stock and cash. The merger agreement provides for additional contingent payments of up to $5 million in stock or cash, under certain circumstances, if stated revenue thresholds are reached over the next three years ending April 30, 2017. Alliqua Inc (NASDAQ:ALQA) weekly performance is -4.61%. On last trading day company shares ended up $6.62. Analysts mean target price for the company is $13.00. Alliqua Inc (NASDAQ:ALQA) distance from 50-day simple moving average (SMA50) is -18.41%.
Raptor Pharmaceutical Corp. (NASDAQ:RPTP) released its earnings data on Thursday. The company reported ($0.20) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.17) by $0.03, Analyst Ratings Network.com reports. The company had revenue of $12.10 million for the quarter, compared to the consensus estimate of $11.81 million. The company’s quarterly revenue was up 120999900.0% on a year-over-year basis. Raptor Pharmaceutical Corp. (NASDAQ:RPTP) shares advanced 3.43% in last trading session and ended the day on $7.83. Its return on assets is -73.00%. Raptor Pharmaceutical Corp. (NASDAQ:RPTP) quarterly performance is -49.52 %.
Zogenix, Inc. (NASDAQ:ZGNX) a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central nervous system disorders, reported that it has issued inducement awards to five new non-executive employees. Zogenix, Inc. (NASDAQ:ZGNX) shares moved down -0.87% in last trading session and was closed at $2.29, while trading in range of $2.07 – $2.31 -. Zogenix, Inc. (NASDAQ:ZGNX) year to date (YTD) performance is -33.43%.
Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, announced its financial results for the fiscal year ended December 31, 2013. Biostar Pharmaceuticals Inc (NASDAQ:BSPM) ended the last trading day at $1.33. Company weekly volatility is calculated as 9.16% and price to cash ratio as 1.80. Biostar Pharmaceuticals Inc (NASDAQ:BSPM) showed a negative weekly performance of -24.00%.